Related references
Note: Only part of the references are listed.Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells
May Daher et al.
BLOOD (2021)
CAR T cell therapies for patients with multiple myeloma
Lekha Mikkilineni et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia
Stephan Mueller et al.
FRONTIERS IN IMMUNOLOGY (2020)
Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial
Maria Castella et al.
FRONTIERS IN IMMUNOLOGY (2020)
IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors
Lauren Giuffrida et al.
MOLECULAR THERAPY (2020)
Highly Efficient Generation of Transgenically Augmented CAR NK Cells Overexpressing CXCR4
Arezoo Jamali et al.
FRONTIERS IN IMMUNOLOGY (2020)
Gene Modified CAR-T Cellular Therapy for Hematologic Malignancies
Wen-Ying Lin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
CAR T-Cells in Multiple Myeloma Are Ready for Prime Time
Paula Rodriguez-Otero et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions
Maria Castella et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Optimization of manufacturing conditions for chimeric antigen receptor T cells to favor cells with a central memory phenotype
Tessa Gargett et al.
CYTOTHERAPY (2019)
Anti-CD19 Chimeric Antigen Receptor T Cells in Combination With Nivolumab Are Safe and Effective Against Relapsed/Refractory B-Cell Non-hodgkin Lymphoma
Yaqing Cao et al.
FRONTIERS IN ONCOLOGY (2019)
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Jae H. Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
Improving Lentiviral Transduction of CD34+ Hematopoietic Stem and Progenitor Cells
Ilona Hauber et al.
HUMAN GENE THERAPY METHODS (2018)
Murine pre-B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptor
Haiying Qin et al.
BLOOD (2018)
Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22
Haiying Qin et al.
MOLECULAR THERAPY-ONCOLYTICS (2018)
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
D. Sommermeyer et al.
LEUKEMIA (2016)
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells (vol 44, pg 380, 2016)
Omkar U. Kawalekar et al.
IMMUNITY (2016)
A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy
Brian Philip et al.
BLOOD (2014)
The Basic Principles of Chimeric Antigen Receptor Design
Michel Sadelain et al.
CANCER DISCOVERY (2013)
Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy
Christian S. Hinrichs et al.
BLOOD (2011)
Manufacturing Validation of Biologically Functional T Cells Targeted to CD19 Antigen for Autologous Adoptive Cell Therapy
Daniel Hollyman et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen Receptor
James N. Kochenderfer et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
Carmine Carpenito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Gene transfer in humans using a conditionally replicating lentiviral vector
Bruce L. Levine et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Optimization of a retroviral vector for transduction of human CD34 positive cells
Anna Szyda et al.
ACTA BIOCHIMICA POLONICA (2006)
Detailed design and comparative analysis of protocols for optimized production of high-performance HIV-1-derived lentiviral particles
B Mitta et al.
METABOLIC ENGINEERING (2005)
Effect of temperature, medium composition, and cell passage on production of herpes-based viral vectors
JB Wechuck et al.
BIOTECHNOLOGY AND BIOENGINEERING (2002)
Share Paper
